PMID- 37683300 OWN - NLM STAT- MEDLINE DCOM- 20230913 LR - 20230913 IS - 2213-2317 (Electronic) IS - 2213-2317 (Linking) VI - 66 DP - 2023 Oct TI - Adverse bioenergetic effects of N-acyl amino acids in human adipocytes overshadow beneficial mitochondrial uncoupling. PG - 102874 LID - S2213-2317(23)00275-6 [pii] LID - 10.1016/j.redox.2023.102874 [doi] LID - 102874 AB - OBJECTIVE: Enhancing energy turnover via uncoupled mitochondrial respiration in adipose tissue has great potential to improve human obesity and other metabolic complications. However, the amount of human brown adipose tissue and its uncoupling protein 1 (UCP1) is low in obese patients. Recently, a class of endogenous molecules, N-acyl amino acids (NAAs), was identified as mitochondrial uncouplers in murine adipocytes, presumably acting via the adenine nucleotide translocator (ANT). Given the translational potential, we investigated the bioenergetic effects of NAAs in human adipocytes, characterizing beneficial and adverse effects, dose ranges, amino acid derivatives and underlying mechanisms. METHOD: NAAs with neutral (phenylalanine, leucine, isoleucine) and polar (lysine) residues were synthetized and assessed in intact and permeabilized human adipocytes using plate-based respirometry. The Seahorse technology was applied to measure bioenergetic parameters, dose-dependency, interference with UCP1 and adenine nucleotide translocase (ANT) activity, as well as differences to the established chemical uncouplers niclosamide ethanolamine (NEN) and 2,4-dinitrophenol (DNP). RESULT: NAAs with neutral amino acid residues potently induce uncoupled respiration in human adipocytes in a dose-dependent manner, even in the presence of the UCP1-inhibitor guanosine diphosphate (GDP) and the ANT-inhibitor carboxyatractylate (CAT). However, neutral NAAs significantly reduce maximal oxidation rates, mitochondrial ATP-production, coupling efficiency and reduce adipocyte viability at concentrations above 25 muM. The in vitro therapeutic index (using induced proton leak and viability as determinants) of NAAs is lower than that of NEN and DNP. CONCLUSION: NAAs are potent mitochondrial uncouplers in human adipocytes, independent of UCP1 and ANT. However, previously unnoticed adverse effects harm adipocyte functionality, reduce the therapeutic index of NAAs in vitro and therefore question their suitability as anti-obesity agents without further chemical modifications. CI - Copyright (c) 2023 The Authors. Published by Elsevier B.V. All rights reserved. FAU - Herrnhold, Marie AU - Herrnhold M AD - Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University, SE-106 91, Stockholm, Sweden. FAU - Hamp, Isabel AU - Hamp I AD - Institute of Medicinal Chemistry, Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; Institute of Organic Chemistry, Leibniz Universitat Hannover, Hannover, Germany. FAU - Plettenburg, Oliver AU - Plettenburg O AD - Institute of Medicinal Chemistry, Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; Institute of Organic Chemistry, Leibniz Universitat Hannover, Hannover, Germany. FAU - Jastroch, Martin AU - Jastroch M AD - Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University, SE-106 91, Stockholm, Sweden. FAU - Keuper, Michaela AU - Keuper M AD - Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University, SE-106 91, Stockholm, Sweden. Electronic address: michaela.keuper@su.se. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230902 PL - Netherlands TA - Redox Biol JT - Redox biology JID - 101605639 RN - 0 (Amino Acids) RN - 5KV86114PT (Ethanolamine) SB - IM MH - Humans MH - Animals MH - Mice MH - *Amino Acids MH - *Adipocytes MH - Ethanolamine MH - Adipose Tissue, Brown MH - Energy Metabolism PMC - PMC10493596 OTO - NOTNLM OT - Adipocytes OT - Metabolism OT - Mitochondria OT - Obesity OT - UCP1 OT - Uncoupling COIS- Declaration of competing interest None. EDAT- 2023/09/08 18:41 MHDA- 2023/09/13 06:41 PMCR- 2023/09/02 CRDT- 2023/09/08 17:59 PHST- 2023/08/10 00:00 [received] PHST- 2023/08/31 00:00 [revised] PHST- 2023/09/01 00:00 [accepted] PHST- 2023/09/13 06:41 [medline] PHST- 2023/09/08 18:41 [pubmed] PHST- 2023/09/08 17:59 [entrez] PHST- 2023/09/02 00:00 [pmc-release] AID - S2213-2317(23)00275-6 [pii] AID - 102874 [pii] AID - 10.1016/j.redox.2023.102874 [doi] PST - ppublish SO - Redox Biol. 2023 Oct;66:102874. doi: 10.1016/j.redox.2023.102874. Epub 2023 Sep 2.